Anti-apoptotic and apoptotic pathway analysis of arsenic trioxide-induced apoptosis in human gastric cancer SGC-7901 cells

Oncology Reports

Volumn 32, Issue 3, 2014, Pages 973-978

  Yu, Yao ^a   Yang, Yu ^a   Wang, Jing ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Anti apoptosis proteins; Apoptosis; Arsenic trioxide; Stomach neoplasms

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ARSENIC TRIOXIDE; CASPASE 8; FAS ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN BAX; PROTEIN KINASE B; ANTINEOPLASTIC AGENT; ORGANOARSENIC DERIVATIVE; OXIDE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION ASSAY; CONCENTRATION RESPONSE; CULTURE MEDIUM; DOWN REGULATION; ENZYME ACTIVATION; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GASTRIC CANCER CELL LINE; GROWTH RATE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SGC 7901 CELL LINE; UPREGULATION; WESTERN BLOTTING; WST ASSAY; CELL NUCLEUS; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OXIDES; STOMACH NEOPLASMS;

EID: 84919476674     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3276     Document Type: Article

References (45)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Lim L, Michael M, Mann GB and Leong T: Adjuvant therapy in gastric cancer. J Clin Oncol 23: 6220-6232, 2005.
3. Wang Y, Zhang Y, Yang L, et al: Arsenic trioxide induces the apoptosis of human breast cancer MCF-7 cells through activation of caspase-3 and inhibition of HERG channels. Exp Ther Med 2: 481-486, 2011.
4. Zhou J: Arsenic trioxide: an ancient drug revived. Chin Med J 125: 3556-3560, 2012.
5. Shen ZY, Shen J, Cai WJ, Hong C and Zheng MH: The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells. Int J Mol Med 5: 155-158, 2000.
6. Shen ZY, Zhang Y, Chen JY, et al: Intratumoral injection of arsenic to enhance antitumor efficacy in human esophageal carcinoma cell xenografts. Oncol Rep 11: 155-159, 2004.
7. Chow SK, Chan JY and Fung KP: Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells. J Cell Biochem 93: 173-187, 2004.
8. Ye J, Li A, Liu Q, Wang X and Zhou J: Inhibition of mitogen-activated protein kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells. Clin Exp Pharmacol Physiol 32: 1042-1048, 2005. (Pubitemid 43906813)
9. Jutooru I, Chadalapaka G, Sreevalsan S, et al: Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth. Exp Cell Res 316: 2174-2188, 2010.
10. Chien CW, Yao JH, Chang SY, Lee PC and Lee TC: Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide. Toxicol Appl Pharmacol 257: 59-66, 2011.
11. Li H, Gong J, Jiang X and Shao H: Arsenic trioxide treatment of rabbit liver VX-2 carcinoma via hepatic arterial cannulation-induced apoptosis and decreased levels of survivin in the tumor tissue. Croat Med J 54: 12-16, 2013.
12. Matulis SM, Morales AA, Yehiayan L, Lee KP, Cai Y and Boise LH: Alterations in glutathione levels and apoptotic regulators are associated with acquisition of arsenic trioxide resistance in multiple myeloma. PloS One 7: e52662, 2012.
13. Ora I, Bondesson L, Jonsson C, et al: Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro. Biochem Biophys Res Commun 277: 179-185, 2000.
14. Nakagawa Y, Akao Y, Morikawa H, et al: Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines. Life Sci 70: 2253-2269, 2002. (Pubitemid 34251296)
15. Bornstein J, Sagi S, Haj A, Harroch J and Fares F: Arsenic trioxide inhibits the growth of human ovarian carcinoma cell line. Gynecol Oncol 99: 726-729, 2005. (Pubitemid 41686559)
16. Liu Y, Zhang W, Zhang X, Qi Y, Huang D and Zhang Y: Arsenic trioxide inhibits invasion/migration in SGC-7901 cells by activating the reactive oxygen species-dependent cyclooxygenase-2/ matrix metalloproteinase-2 pathway. Exp Biol Med 236: 592-597, 2011.
17. Bowling BD, Doudican N, Manga P and Orlow SJ: Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism. Cancer Chemother Pharmacol 63: 37-43, 2008.
18. Florea AM and Büsselberg D: Anti-cancer drugs interfere with intracellular calcium signaling. Neurotoxicology 30: 803-810, 2009.
19. Gao F, Yi J, Shi GY, Li H, Shi XG and Tang XM: The sensitivity of digestive tract tumor cells to As2O3 is associated with the inherent cellular level of reactive oxygen species. World J Gastroenterol 8: 36-39, 2002. (Pubitemid 34154843)
20. Izdebska M, Grzanka A, Szczepanski MA and Litwiniec A: Selected mechanisms of the therapeutic effect of arsenic trioxide in cancer treatment. Postepy Hig Med Dosw 62: 463-467, 2008 (In Polish).
21. Calvino E, Estan MC, Simon GP, et al: Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation. Biochem Pharmacol 82: 1619-1629, 2011.
22. Carracedo A and Pandolfi PP: The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 27: 5527-5541, 2008.
23. Markman B, Dienstmann R and Tabernero J: Targeting the PI3K/Akt/mTOR pathway - beyond rapalogs. Oncotarget 1: 530-543, 2010.
24. Hay N: The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8: 179-183, 2005.
25. He C and Klionsky DJ: Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43: 67-93, 2009.
26. Meijer AJ and Codogno P: Regulation and role of autophagy in mammalian cells. Int J Biochem Cell Biol 36: 2445-2462, 2004. (Pubitemid 39119758)
27. Redondo-Munoz J, Escobar-Diaz E, Hernandez Del Cerro M, et al: Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation. Clin Cancer Res 16: 4382-4391, 2010.
28. Ghobrial IM, Witzig TE and Adjei AA: Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55: 178-194, 2005. (Pubitemid 40826487)
29. Komarov AP, Rokhlin OW, Yu CA and Gudkov AV: Functional genetic screening reveals the role of mitochondrial cytochrome b as a mediator of FAS-induced apoptosis. Proc Natl Acad Sci USA 105: 14453-14458, 2008.
30. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993. (Pubitemid 23259742)
31. Suen DF, Norris KL and Youle RJ: Mitochondrial dynamics and apoptosis. Genes Dev 22: 1577-1590, 2008. (Pubitemid 351846838)
32. Han B, Zhou G, Zhang Q, et al: Effect of arsenic trioxide (ATO) on human lung carcinoma PG cell line: ATO induced apoptosis of PG cells and decreased expression of Bcl-2, Pgp. J Exp Ther Oncol 4: 335-342, 2004. (Pubitemid 40192579)
33. Guertin DA and Sabatini DM: Defining the role of mTOR in cancer. Cancer Cell 12: 9-22, 2007. (Pubitemid 47001784)
34. Sarbassov DD, Guertin DA, Ali SM and Sabatini DM: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101, 2005. (Pubitemid 40262113)
35. Brunet A, Bonni A, Zigmond MJ et al: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868, 1999. (Pubitemid 29165088)
36. Diehl JA, Cheng M, Roussel MF and Sherr CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-3511, 1998. (Pubitemid 28553242)
37. Engelman JA, Luo J and Cantley LC: The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-619, 2006. (Pubitemid 44100518)
38. Chen YC, Lin-Shiau SY and Lin JK: Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol 177: 324-333, 1998.
39. Woo SH, Park IC, Park MJ, et al: Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells. Int J Oncol 21: 57-63, 2002.
40. Pelicano H, Feng L, Zhou Y, et al: Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem 278: 37832-37839, 2003. (Pubitemid 37175311)
41. Diepart C, Karroum O, Magat J, et al: Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors. Cancer Res 72: 482-490, 2012.
42. Ling LU, Tan KB, Lin H and Chiu GN: The role of reactive oxygen species and autophagy in sa.ngol-induced cell death. Cell Death Dis 2: e129, 2011.
43. Zhang G, Liu J, Zhang Y, et al: Cbl-b-dependent degradation of FLIP(L) is involved in ATO-induced autophagy in leukemic K562 and gastric cancer cells. FEBS Lett 586: 3104-3110, 2012.
44. Cheng Y, Qiu F, Ye YC, et al: Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells. FEBS J 276: 1291-1306, 2009.
45. Dai J, Weinberg RS, Waxman S and Jing Y: Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93: 268-277, 1999. (Pubitemid 29019412)